Production (Stage)
Ardent Health Partners, Inc.
ARDT
$14.62
-$0.18-1.22%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.02B | 5.97B | 5.71B | 5.63B | 5.53B |
| Total Other Revenue | -- | 22.95M | 22.95M | 22.95M | 22.95M |
| Total Revenue | 6.02B | 5.97B | 5.71B | 5.63B | 5.53B |
| Cost of Revenue | 2.57B | 2.53B | 2.48B | 2.44B | 2.41B |
| Gross Profit | 3.45B | 3.43B | 3.23B | 3.19B | 3.12B |
| SG&A Expenses | 2.40B | 2.38B | 2.34B | 2.31B | 2.27B |
| Depreciation & Amortization | 147.14M | 146.29M | 144.42M | 143.13M | 141.49M |
| Other Operating Expenses | 505.15M | 496.22M | 464.56M | 471.50M | 465.02M |
| Total Operating Expenses | 5.63B | 5.56B | 5.43B | 5.36B | 5.29B |
| Operating Income | 397.03M | 405.76M | 274.38M | 269.01M | 244.69M |
| Income Before Tax | 380.69M | 363.06M | 204.64M | 193.54M | 179.18M |
| Income Tax Expenses | 67.87M | 63.35M | 35.04M | 31.24M | 28.13M |
| Earnings from Continuing Operations | 312.82 | 299.71 | 169.60 | 162.30 | 151.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -88.14M | -89.37M | -77.61M | -75.80M | -74.24M |
| Net Income | 224.68M | 210.34M | 91.99M | 86.50M | 76.81M |
| EBIT | 397.03M | 405.76M | 274.38M | 269.01M | 244.69M |
| EBITDA | 544.17M | 552.05M | 418.79M | 412.14M | 386.18M |
| EPS Basic | 1.64 | 1.56 | 0.71 | 0.69 | 0.61 |
| Normalized Basic EPS | 1.01 | 0.94 | 0.40 | 0.36 | 0.25 |
| EPS Diluted | 1.63 | 1.55 | 0.71 | 0.69 | 0.61 |
| Normalized Diluted EPS | 1.01 | 0.94 | 0.40 | 0.36 | 0.25 |
| Average Basic Shares Outstanding | 543.33M | 529.38M | 515.45M | 504.46M | 504.46M |
| Average Diluted Shares Outstanding | 545.19M | 530.60M | 515.89M | 504.46M | 504.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |